Liminatus Pharma, Inc. Class A Common Stock Financial Flexibility Index
Liminatus Pharma, Inc. Class A Common Stock financial flexibility index. Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a Financial Flexibility Index of -0.31x as of June 2026. Free cash flow of $-970.00K (operating CF $-970.00K minus capex $0.00) represents 0% of total liabilities ($3.10 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Liminatus Pharma, Inc. Class A Common Stock (2021–2025)
Financial flexibility index of Liminatus Pharma, Inc. Class A Common Stock from 2021 to 2025. Historical Financial Flexibility Index trend for Liminatus Pharma, Inc. Class A Common Stock across 5 annual periods. Check how high is Liminatus Pharma, Inc. Class A Common St's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Liminatus Pharma, Inc. Class A Common Stock Financial Flexibility Index by Year (2021–2025)
Liminatus Pharma, Inc. Class A Common Stock financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for Liminatus Pharma, Inc. Class A Common Stock. For the full cash flow conversion analysis, see cash efficiency ratio of Liminatus Pharma, Inc. Class A Common St.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.96x | $-9.95 Million | $-9.96 Million | $10.33 Million | ▼ -479.9% |
| 2024 | -0.17x | $-3.11 Million | $-3.11 Million | $18.70 Million | ▲ +24.5% |
| 2023 | -0.22x | $-3.35 Million | $-3.35 Million | $15.19 Million | ▼ -259.6% |
| 2022 | -0.06x | $-869.00K | $-869.00K | $14.19 Million | ▼ -8.6% |
| 2021 | -0.06x | $-1.22 Million | $-1.22 Million | $21.57 Million | — |